SpinTech continues to extend the boundaries of MRI and recently earned FDA clearance for STAGE, a rapid, quantitative multi-contrast imaging software that integrates seamlessly into existing clinical workflows. STAGE includes the world’s first FDA cleared QSM output and can be used across a wide range of neurodegenerative disorders such as stroke, Multiple Sclerosis, Parkinson’s, traumatic brain injury, dementia, and tumor imaging. In addition, SpinTech offers automated CMB and Parkinson’s Reports that run on top of STAGE data to aid clinicians in detecting microbleeds and quantifying neuromelanin content, respectively.

Medical Devices

SpinTech MRI

Karen Holzberger

Mark Haacke

Jeff Eardley

James Backstrom

John Ciliberto

Paul Kokeny

Kiarash Ghassaban

Rana El Hachem

Miller Fawaz

Rachel Martis-Laze

- University of Michigan, Biomedical EngineeringThe founding team at SpinTech MRI has a history of being professors at Wayne State University and the MRI Institute, as well as the host of Great Lakes Now at Detroit Public Television. They have also been commercialization advisors at genus, LLC and principals at Sextant Innovations. Lastly, they have been the Associate Director of Innovations at Henry Ford Health System Innovations. Their education histories include Northwestern University for Economics and the University of Michigan for Biomedical Engineering.

Founding Team

Leadership Team

CEO and Executive Team

Founding Team

About

Team members

Other teams at SpinTech MRI

Leadership Team

CEO and Executive Team